no.ibarra
Submits third-party assay reports on material purchased directly. Based in Coimbra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.52%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042260 | KPV | TFC | TFC-2508-M9624 | PeptideMeter | 2026-Q1 | 99.93 | 2.89 | 99.2 | Buyer-sourced | 0 | FAIL |
| AX-2025-018982 | Oxytocin | ASY | ASY-{CAT}-1898 | Janoshik | 2025-Q4 | 99.93 | 4.26 | 97.3 | Buyer-sourced | 0 | PASS |
| AX-2025-021001 | Tirzepatide | WXT | WXT-2505-T3334 | Janoshik | 2025-Q3 | 98.13 | 3.50 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018652 | MK-677 (Ibutamoren mesylate) | QSC | QSC-2507-F5673 | Janoshik | 2025-Q3 | 99.52 | 4.27 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-020235 | Retatrutide | GGPeps | GGPE-2508-E1731 | Nordanalyt | 2025-Q3 | 97.69 | 2.63 | 96.3 | Buyer-sourced | 0 | PASS |
| AX-2025-018954 | Tirzepatide | ASY | ASY-{CAT}-1244 | Janoshik | 2025-Q1 | 98.80 | 4.86 | 106.3 | Buyer-sourced | 0 | PASS |
| AX-2025-019826 | KPV | Homopeptide | HOMO-2411-P5026 | Janoshik | 2025-Q1 | 99.64 | 4.71 | 106.5 | Buyer-sourced | 0 | FAIL |